SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-006076
Filing Date
2019-04-29
Accepted
2019-04-29 16:15:25
Documents
11
Period of Report
2019-04-29
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 798395
2 logo_001.jpg GRAPHIC 5073
3 logo_002.jpg GRAPHIC 5667
4 annex_001.jpg GRAPHIC 177701
5 annex_002.jpg GRAPHIC 130199
6 annex_003.jpg GRAPHIC 177747
7 annex_004.jpg GRAPHIC 130264
8 annex_005.jpg GRAPHIC 177555
9 annex_006.jpg GRAPHIC 130199
10 annex_007.jpg GRAPHIC 177571
11 annex_008.jpg GRAPHIC 130264
  Complete submission text file 0001493152-19-006076.txt   2511490
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37769 | Film No.: 19776070
SIC: 2834 Pharmaceutical Preparations